BackMadrigal Pharmaceuticals Overview

Madrigal Pharmaceuticals Total Assets

Latest total assets for MDGL: $1.4B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$1.43B
↑ 5.28% YoYΔ $71.93M vs prior year quarter

Peer trimmed avg / median

Loading

Madrigal Pharmaceuticals Total Assets History

Loading

Madrigal Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Madrigal Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Madrigal Pharmaceuticals (MDGL) FAQ

The latest total assets for MDGL is $1.4B as of September 2026. That compares with $1.4B in the prior-year period — up 5.3% year over year. Investors often review this figure alongside Madrigal Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, MDGL's total assets moved from $1.4B to $1.4B — a 5.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Madrigal Pharmaceuticals's operating scale or balance-sheet position.

A total assets figure of $1.4B for MDGL is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MDGL's total assets ($1.4B), review year-over-year change from $1.4B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Madrigal Pharmaceuticals's total assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.